MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053530 A) filed by Umoja Biopharma, Inc., Seattle, on June 2, for 'particles displaying adhesion-molecule fusions.'
Inventor(s) include Nicolai, Christopher; Tang, Weiliang; Ryu, Byoung; Larson, Ryan; Qin, Jim; Gottschalk, Rebecca, Jane; Leung, Wai-Hang; and Park, Lisa, Yun.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "Provided herein are particles comprising a fusion molecule comprising an adhesion molecule linked to a costimulatory molecule or an activation molecule, as well as vectors, such as lentiviral vectors, comprising the same, cells comprising the same, and methods of using the same. The particle may be a lentiviral particle that displays on the surface of the particle a fusion molecule comprising: a) a CD58 extracellular domain, or a functional fragment thereof, b) an antigen-binding fragment of an anti-CD3 antibody, and c) a CD80 or CD86 extracellular domain, or a functional fragment thereof, and a viral glycoprotein (G protein)."
The patent application was internationally filed on Nov. 03, 2023, under International application No.PCT/US2023/078688.
Disclaimer: Curated by HT Syndication.
